Renyi Qin

1.6k total citations
44 papers, 1.0k citations indexed

About

Renyi Qin is a scholar working on Oncology, Molecular Biology and Surgery. According to data from OpenAlex, Renyi Qin has authored 44 papers receiving a total of 1.0k indexed citations (citations by other indexed papers that have themselves been cited), including 28 papers in Oncology, 15 papers in Molecular Biology and 13 papers in Surgery. Recurrent topics in Renyi Qin's work include Pancreatic and Hepatic Oncology Research (21 papers), Cancer-related molecular mechanisms research (8 papers) and Pancreatitis Pathology and Treatment (7 papers). Renyi Qin is often cited by papers focused on Pancreatic and Hepatic Oncology Research (21 papers), Cancer-related molecular mechanisms research (8 papers) and Pancreatitis Pathology and Treatment (7 papers). Renyi Qin collaborates with scholars based in China, United States and Italy. Renyi Qin's co-authors include Xingjun Guo, Chengjian Shi, Ming Shen, Fangyu Guo, Zhixin Chen, Jing Hao, Junwen M. Hu, Youpeng Ding, Zhiyong Du and Ruizhi He and has published in prestigious journals such as SHILAP Revista de lepidopterología, British Journal of Cancer and International Journal of Cancer.

In The Last Decade

Renyi Qin

42 papers receiving 1.0k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Renyi Qin China 19 538 463 458 201 116 44 1.0k
Arihiro Aihara Japan 19 513 1.0× 327 0.7× 408 0.9× 180 0.9× 65 0.6× 45 999
Wenhui Lou China 19 418 0.8× 388 0.8× 582 1.3× 233 1.2× 178 1.5× 62 1.1k
Tiantao Kuang China 19 566 1.1× 451 1.0× 718 1.6× 252 1.3× 238 2.1× 58 1.3k
Valerie Grose United States 6 848 1.6× 374 0.8× 246 0.5× 136 0.7× 137 1.2× 11 1.3k
Wen-Quan Wang China 16 316 0.6× 273 0.6× 583 1.3× 149 0.7× 101 0.9× 20 903
Hua-Xiang Xu China 15 311 0.6× 268 0.6× 574 1.3× 146 0.7× 98 0.8× 19 886
Yinmo Yang China 18 623 1.2× 428 0.9× 560 1.2× 259 1.3× 92 0.8× 75 1.1k
Chun-Tao Wu China 14 324 0.6× 263 0.6× 545 1.2× 143 0.7× 93 0.8× 19 877
Garcilaso Riesco‐Eizaguirre Spain 16 568 1.1× 215 0.5× 294 0.6× 122 0.6× 75 0.6× 31 1.2k

Countries citing papers authored by Renyi Qin

Since Specialization
Citations

This map shows the geographic impact of Renyi Qin's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Renyi Qin with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Renyi Qin more than expected).

Fields of papers citing papers by Renyi Qin

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Renyi Qin. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Renyi Qin. The network helps show where Renyi Qin may publish in the future.

Co-authorship network of co-authors of Renyi Qin

This figure shows the co-authorship network connecting the top 25 collaborators of Renyi Qin. A scholar is included among the top collaborators of Renyi Qin based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Renyi Qin. Renyi Qin is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Liu, Yu-Hui, Ruizhi He, Wenjia Wang, et al.. (2025). Dysregulated RNA m6A Methylation Contributes to the Metastasis of Gallbladder Cancer Through miR‐146a‐5p. Journal of Cellular and Molecular Medicine. 29(15). e70764–e70764. 1 indexed citations
2.
Wei, Kongyuan, Meidai Kasai, Benedetto Ielpo, et al.. (2023). Minimally invasive versus open pancreatoduodenectomy for pancreatic ductal adenocarcinoma: Individual patient data meta-analysis of randomized trials. European Journal of Surgical Oncology. 49(8). 1351–1361. 17 indexed citations
3.
He, Ruizhi, Taoyuan Yin, Shutao Pan, et al.. (2022). One hundred most cited article related to pancreaticoduodenectomy surgery: A bibliometric analysis. International Journal of Surgery. 104. 106775–106775. 7 indexed citations
4.
Xiong, Guangbing, Jiali Li, Xingjun Guo, et al.. (2021). Predictive factors of postoperative pancreatic fistula after laparoscopic pancreatoduodenectomy. Annals of Translational Medicine. 9(1). 41–41. 9 indexed citations
5.
Zhou, Min, Yang Gao, Min Wang, et al.. (2021). MiR-146b-3p regulates proliferation of pancreatic cancer cells with stem cell-like properties by targeting MAP3K10. Journal of Cancer. 12(12). 3726–3740. 16 indexed citations
6.
Peng, Feng, et al.. (2021). Prognostic significance of preoperative Naples prognostic score on short- and long-term outcomes after pancreatoduodenectomy for ampullary carcinoma. HepatoBiliary Surgery and Nutrition. 10(6). 825–838. 20 indexed citations
7.
Shen, Yinan, Chengxiang Guo, Yao Pan, et al.. (2018). Preoperative prediction of peripancreatic vein invasion by pancreatic head cancer. Cancer Imaging. 18(1). 49–49. 10 indexed citations
8.
Shi, Xiuhui, Xingjun Guo, Xu Li, Min Wang, & Renyi Qin. (2018). Loss of Linc01060 induces pancreatic cancer progression through vinculin-mediated focal adhesion turnover. Cancer Letters. 433. 76–85. 26 indexed citations
9.
Shen, Yinan, Xueli Bai, Gang Jin, et al.. (2018). A preoperative nomogram predicts prognosis of up front resectable patients with pancreatic head cancer and suspected venous invasion. HPB. 20(11). 1034–1043. 12 indexed citations
10.
Chen, Hua, Chunle Zhao, Ruizhi He, et al.. (2018). Danthron suppresses autophagy and sensitizes pancreatic cancer cells to doxorubicin. Toxicology in Vitro. 54. 345–353. 37 indexed citations
11.
Xu, Xiaodong, Jun Hu, Min Wang, et al.. (2016). Circulating myeloid-derived suppressor cells in patients with pancreatic cancer. Hepatobiliary & pancreatic diseases international. 15(1). 99–105. 42 indexed citations
12.
Hu, Yufeng, Hexiu Su, Xu Li, et al.. (2014). The NOTCH Ligand JAGGED2 Promotes Pancreatic Cancer Metastasis Independent of NOTCH Signaling Activation. Molecular Cancer Therapeutics. 14(1). 289–297. 26 indexed citations
13.
Li, Xu, Min Wang, Zheng He, et al.. (2013). Apoptosis of human gallbladder carcinoma GBC-SD cells induced by withaferin A and its possible mechanism. Tumori. 33(6). 502–508. 1 indexed citations
14.
Peng, Feng, Jianxin Jiang, Rui Tian, et al.. (2013). Direct targeting of SUZ12/ROCK2 by miR-200b/c inhibits cholangiocarcinoma tumourigenesis and metastasis. British Journal of Cancer. 109(12). 3092–3104. 88 indexed citations
15.
Zhu, Feng & Renyi Qin. (2012). Prior selective arteriovenous treatment in radical pancreaticoduodenectomy. Zhōnghuá xiāohuà wàikē zázhì/Zhonghua xiaohua waike zazhi. 11(4). 355–358.
16.
Qin, Renyi, et al.. (2011). Efficacy of simplified binding pancreaticojejunostomy. Zhōnghuá xiāohuà wàikē zázhì/Zhonghua xiaohua waike zazhi. 10(2). 129–131. 1 indexed citations
17.
Zhang, Jianli, Jun Gao, Xiaojie Tan, Min Wang, & Renyi Qin. (2010). Effects of down-regulation of integrin-β1 expression on migration and hepatic metastasis of human colon carcinoma. Journal of Huazhong University of Science and Technology [Medical Sciences]. 30(4). 464–469. 8 indexed citations
18.
Liu, Wensong, Haijiao Yan, Renyi Qin, et al.. (2008). siRNA Directed Against Survivin Enhances Pancreatic Cancer Cell Gemcitabine Chemosensitivity. Digestive Diseases and Sciences. 54(1). 89–96. 40 indexed citations
19.
Chang, Qing, et al.. (2004). Survivin expression induced by doxorubicin in cholangiocarcinoma. World Journal of Gastroenterology. 10(3). 415–415. 18 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026